To evaluate the incremental value of low endothelial shear stress (ESS) combined with high-resolution magnetic resonance imaging (MRI)-and computed tomography angiography (CTA)-based imaging for the prediction of inflamed plaque.
Introduction
Non-invasive identification and prediction of atherosclerotic plaque with high-risk characteristics remains a difficult challenge. Inflammation indubitably influences the pathogenesis of high-risk plaques. 1 -3 Lesions that provoke fatal myocardial infarctions plaque often display increased wall thickness, luminal irregularities, and high lipid and macrophage but low calcium content. 4, 5 Experimental studies have shown that low endothelial shear stress (ESS) associates strongly with inflammation and lipid accumulation, promoting atherogenesis, plaque formation, and progression to vulnerability. 6 -8 However, limited data exist on the role of ESS for plaque evolution derived from serial non-invasive imaging studies. Non-invasive imaging can identify different plaque constituents. High-resolution magnetic resonance imaging (MRI) with ultra-small superparamagnetic nanoparticles (USPIOs) can identify plaque inflammation 9 and assess disease progression. 10 -12 Plaque macrophages phagocytize USPIOs detectable by MRI using dedicated off-resonance sequences. 9,13 -17 Computed tomography angiography (CTA), on the other hand, can visualize regions of low attenuation or spotty calcification, 18, 19 characteristic that associated with prospective risk of acute coronary syndromes. 20 -24 Conceptually, a combined assessment of ESS and inflammation may have incremental value for the identification of high-risk plaque. This experimental study investigated the hypothesis that combined non-invasive calculation of ESS by CTA and imaging of inflammation by USPIO-enhanced MRI can predict the development of inflamed plaque. These experiments used genetically hyperlipidaemic rabbits, animals that develop inflamed macrophage-rich aortic plaques.
Methods

Study animals and design
The study was approved by the Institutional Animal Care and Use Committee. Experiments were conducted in 12 male heritable hyperlipidaemic Watanabe WHHL-MI rabbits (2.2 -3.2 kg body weight), which received ketamine (50 mg/kg) and xylazine (20 mg/kg) intramuscularly for general anaesthesia during all imaging studies. Table 1 shows the characteristics of study animals. All rabbits consumed a normal chow diet; they appeared healthy and active throughout the study period and had normal life span.
The animals underwent MRI (before and after USPIO injection) and CTA at baseline (age: 7.5 + 0.1 months) and at follow-up (age: 13.0 + 0.2 months) ( Figure 1) . ESS in the thoracic aorta was assessed noninvasively at baseline via computational fluid dynamics (CFD) using 3D reconstructions of the aortic lumen from contrast-enhanced CT angiography. At the end of the study, animals underwent euthanasia using an overdose of thiopental. The aortas were then isolated and analysed histopathologically for inflammation, lipids, and calcification.
Serial MRI studies
MRI studies were performed with a clinical 1.5 T system (Achieva, Philips Healthcare, Best, The Netherlands) using a 32-element cardiac phased-array receiver coil. The detailed imaging protocol is provided in the Supplementary data online. For the assessment of plaque inflammation, we performed high-resolution off-resonance MRI using USPIO as contrast material (250 mmol Fe/Kg; P904 provided by Guerbet, Villepinte, France), as previously described. 9 A dedicated off-resonance MRI sequence (Inversion Recovery with ON-Resonant water suppression, IRON-MRI) evaluated the regional USPIO uptake by the macrophages, as previously described. 9 Animals were imaged with MRI immediately before the USPIO injection and 4 days later 9 ( Figure 1 ).
Serial CTA studies
CTA images were acquired using a clinical 256-slice CT scanner (iCT, Philips Medical Systems, Best, The Netherlands) immediately after the molecular MRI ( Figure 1) . A standardized retrospective electrocardiogram-gated protocol focused on anatomical highresolution visualization of the aortic vessel was applied. The detailed imaging protocol is provided in the Supplementary data online.
3D reconstruction of aortas and CFD at baseline
Aortic CTA acquisitions were routinely reconstructed at the diastolic phase (75% phase). This image data set was segmented from aortic valve to the infrarenal level, along with the major branches (right and left innominate and renal arteries). At baseline, the aortas (from the aortic valve to the infrarenal level) along with the major branches (right and left innominate and renal arteries) underwent multiplanar reformatting and semiautomatic segmentation using a clinical image post-processing workstation (Vitrea 6.4, Vital Images, A Toshiba Medical Systems Group, Minnetonka, MN, USA). Customized software developed in Matlab (Matlab R2013a, Mathworks, Natick, MA, USA) permitted creation of a 3D mesh of the reconstructed arterial volumes. The mesh consisted of tetrahedral elements plus five prismatic layers close to the wall to capture near-wall effects. The baseline ESS was calculated from the aorta 3D mesh representations using a commercially available CFD software (Fluent 15, ANSYS Inc., PA, USA) ( Figure 2A) . The inlet velocity of each reconstructed aorta at the level of the aortic valve was calculated by the ratio of blood flow assessed by 2D velocity-encoding phase-contrast MRI over the aortic valve area. Flow was considered as 3D, steady, laminar, isothermal with no external forces applied on it, and the arterial wall was assumed to be non-elastic and impermeable. Blood was assumed to obey a non-Newtonian power law model and to have constant density. ESS distribution was represented using 2D maps with arterial length (mm) in the x-axis and artery circumference (degrees) in the y-axis ( Figure 2B ).
Identification of convex (outer curvature) and concave (inner curvature) wall subsegments of interest at baseline All analyses were performed in the thoracic portion of the aorta. The reconstructed aortas were divided into 5-mm-long segments. In the ascending aorta and aortic arch, all sequential segments were analysed, whereas in the thoracic aorta we selected two to three representative segments. To account for the circumferential (convex vs. concave wall) heterogeneity in ESS patterns across a given aorta, each 5-mm-long segment was further divided into the convex curvature subsegment, extending clockwise from 260 to +608, and the concave curvature subsegment extending clockwise from +120 to 21208 (Figure 2A) . The longitudinal line across the convex curvature passing through the middle of the ostium of the right innominate was set as 08.
The average ESS was calculated in the convex and concave subsegments. To account for the inter-aorta ESS heterogeneity, the average ESS in each subsegment was classified into low, moderate, and high based on the frequency distribution of ESS values in each aorta: (i) low ESS subsegment if average ESS ≤25th percentile of the frequency distribution, (ii) intermediate ESS subsegment if average ESS between 25th and 75th percentile of the frequency distribution, and (iii) high ESS subsegment if average ESS ≥75th percentile of the frequency distribution.
Longitudinal and circumferential co-registration of imaging modalities, CFD, and histopathology Shear stress, non-invasive imaging of inflammation and inflamed plaque point of the ostium of the right innominate artery as a fixed anatomical landmark and set it as 0 mm. To identify and match the convex and concave curvature in each modality and in histology, we used the longitudinal line of the convex curvature passing through the middle of the ostium of the right innominate and we set it as 08.
Aortic wall thickness and inflammation by MRI
The aortic wall thickness was measured in cross-sections corresponding to the middle of 5-mm-long segments using pre-contrast black-blood turbo field echo MR images (BB-TFE-MRI) at baseline and follow-up as previously described (Soapbubble software tool, release 5.1 for PRIDE V4.*+V5, Philips Healthcare, Best, The Netherlands). 25 The USPIO concentration-dependent image contrast ratio, an indication of inflammation in the aortic wall, was calculated using the normalized enhancement ratio (NER) according to the following formula as previously described:
where SNR corresponded to the signal-to-noise-ratio in regions of interest placed in the aortic wall and the adjacent aortic lumen in the pre-and post-USPIO images. 9 The matching between the pre-and post-USPIO images used fiducial landmarks, including the aortic bulb, supra-aortic branches, and the vertebral bodies. Increased vessel wall enhancement was indicated by a NER of .1. Two blinded experts performed all measurements of the aortic wall thickness and NER.
Aortic wall analysis by CTA
Quantitative aortic wall analysis in CTA was performed with Plaque 
Histopathology
Histopathological analysis was performed to assess the plaque area (mm 2 ), calcification (calcified area over plaque area, %), lipids (lipid area over plaque area, %), and macrophages (macrophage area over plaque area, %). Supplementary data online provides a detailed description of the histopathological analysis, which were performed by two blinded experts.
Statistical analyses
Statistical analyses were performed with MedCalc 15.2.2 (MedCalc Software, Mariakerke, Belgium), IBM SPSS Statistics 21.0 (IBM Corp., New York, NY, USA) for mixed-effects analysis and with Graph Pad Prism version 5 (GraphPad Software, La Jolla, CA, USA). Continuous variables were summarized as mean + standard error of mean (SEM) and categorical variables as actual numbers and percentages. Several statistical methods corrected for systematic error introduced by the clustering of aortic subsegments within animals. First, investigation of the association of continuous dependent variables (e.g. increase of NER, wall thickness, and macrophage content) with categorical independent variables (e.g. baseline ESS) used mixed-effects one-way analysis of variance (ANOVA) with the animals specified as random effects and with post hoc Scheffé test for pairwise comparisons. Second, the association of continuous variables used mixed-effects linear regression with the animals specified as random effects. The Huber White sandwich estimator adjusted the SEs of the regression coefficient for clustering of arterial subsegments within animals in linear regression and logistic regression analyses. In linear prediction models, linear model validity was tested using the Cusum test. A receiver operating curve (ROC) analysis assessed the predictive value of baseline ESS and baseline NER for the development of macrophage-and lipid-rich plaques as validated by histopathological examination. The inter-and intra-observer (8 weeks apart) agreement of MRI and CTA measurements used Pearson's correlation, coefficient linear regression analysis, and Bland -Altman analysis in a representative sample of 20 images. P-value of ≤0.05 was considered as the level of statistical significance.
Results
All study animals completed the follow-up. All animals had MRI at baseline and follow-up. For technical reasons, four rabbits did not undergo baseline CTA, but all animals had follow-up CTA.
Baseline ESS
A total of 88 concave wall and convex wall subsegments were identified. Three subsegments (n ¼ 3) were excluded from final analysis due to reduced image quality in MRI. At baseline, the concave wall subsegments had predominantly low ESS, whereas convex wall subsegments had higher ESS (Figure 2A ). This pattern of circumferential ESS distribution was most evident in the aortic arch and descending thoracic aorta. Figure 3B -F ) . The increase in wall thickness in subsegments with low baseline ESS exceeded the intra-and inter-observer variability of wall thickness measurements by MRI (1.1 + 1.8 and 1.6 + 2.0%, respectively).
Association of low baseline ESS with wall thickness increase by MRI
Association of low baseline ESS with plaque burden at follow-up by CTA Non-calcified plaque area and volume at follow-up were 1.8-and 2.4-fold higher in regions of low vs. high baseline ESS (plaque area: 1.68 + 0.13 vs. 0.95 + 0.05 mm 2 , P , 0.001; plaque volume:
2.14 + 0.21 vs. 0.91 + 0.07 mm 3 , P , 0.001; Figure 4A and B). Association of low baseline ESS with high-risk plaque features determined by histopathological analysis 
Association of low baseline ESS with inflammation progression by molecular MRI
Serial IRON-MRI before and after the administration of USPIO at baseline and at 6 months showed quantifiable changes in signal intensity within the aortic wall by NER. Specifically, NER at follow-up associated significantly with non-calcified plaque area by CTA (y ¼ 1.95x -1.26, P , 0.001) and with macrophage content determined histopathologically (y ¼ 13.37x -8.30, P , 0.001; Figure 6A ), showing that NER accurately tracks plaque inflammation. Using a ROC-adjusted cut-off value of macrophage density .5.3% to differentiate between macrophage-rich vs. macrophage-poor plaque, ROC-analysis identified a NER value at follow-up of ≥1.23 to be highly associated with macrophage-rich plaques (AUC ¼ 0.989; 95% CI 0.933 -1.00; P , 0.0001). Non-calcified plaque area in CTA correlated well with macrophage content measured immunohistochemically (y ¼ 4.51x + 2.38, P , 0.001, Figure 6B ). At baseline, low ESS subsegments co-localized with significantly higher NER compared with that co-localized with higher ESS subsegments ( Figure 6C ). Figure 6D and E). The increase in NER in areas with low baseline ESS exceeded the intra-and inter-observer variability of NER measurements (1.9 + 1.3 and 2.8 + 4.3%, Shear stress, non-invasive imaging of inflammation and inflamed plaque respectively). Figure 6F -H shows a representative example of NER progression in convex and concave subsegments with low baseline ESS. Figure 7A -K shows a non-calcified plaque by CTA, with colocalized elevated NER in USPIO-enhanced IRON-MRI ( Figure 7G and J ), and increased accumulation of inflammatory cells determined histopathologically ( Figure 7H and K) . This plaque developed in a convex wall subsegment of the arch with low ESS at baseline ( Figure 7A) . In contrast, an aortic subsegment with high baseline ESS ( Figure 7B ) showed no evidence of plaque by CTA ( Figure 7C) , with no NER in USPIO-enhanced IRON-MRI ( Figure 7D) , and absence of plaque by histopathology ( Figure 7E ). Table 3) .
Inter-and intra-observer agreement
There was excellent inter-and intra-observer agreement for wall thickness by conventional MRI, NER by molecular MRI, and plaque burden by CTA ( Table 4) .
Discussion
This in vivo experimental study used serial conventional and USPIO-enhanced IRON-MRI and high-resolution CTA imaging to assess plaque changes in the aortas of rabbits with genetic hyperlipidaemia. Histopathological validation demonstrated that (i) low baseline ESS associates with progression of inflamed plaque, and (ii) the combination of low ESS with increased USPIO uptake in IRON-MRI strongly predicts development of inflamed plaque. This proof-of-concept study provides a rationale for future investigations in humans using non-invasive high-resolution imaging and CFD to identify plaques with high-risk characteristics. The ability to predict the development of such plaques non-invasively could facilitate the development of novel therapies to reduce atherosclerotic complications.
Non-invasive assessment of plaque inflammation by USPIO uptake in molecular MRI Inflammatory burden influences plaque stability and clinical outcomes. 1,27 -31 Several strategies strive to assess arterial inflammation and macrophages including soluble biomarkers, and noninvasive and invasive imaging.
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F-FDG PET and targeted PET tracers provide non-invasive approaches for quantitative assessment of plaque inflammation. 29, 30 On the other hand, increased USPIO uptake by macrophages reflects their phagocytic activity. The current study Shear stress, non-invasive imaging of inflammation and inflamed plaque evaluated the severity of plaque inflammation by application of offresonance IRON-MRI to assess the signal intensity of USPIO with simultaneous intrinsic background suppression. 32 The use of this particular off-resonance imaging technique instead of traditional T2-or T2*-weighted protocols avoided intensity changes, which could artificially occur from increased free water from inflammation-associated local edema 33, 34 or presence of reactive oxygen species. 33 Our findings agree with previous studies showing that high-resolution MRI using USPIOs can identify plaque inflammation and its changes during atherogenesis. 9, 10, 12, 35 Non-invasive assessment of plaque composition in CTA CTA can non-invasively characterize and quantify atherosclerotic plaques. 36, 37 CTA enables detection and evaluation of serial changes in plaque. 38, 39 More recent investigations have linked the severity of plaque inflammation with non-calcified plaque composition by CTA. 40, 41 Beyond these observations, the present study used an innovative approach of combined USPIO-enhanced IRON-MRI with highresolution CTA to detect a significant association of non-calcified plaque burden by CTA with inflammatory burden by USPIO uptake in IRON-MRI and lipid and macrophage content with histomorphometric validation. The results highlight the potential of the multimodality non-invasive imaging to identify inflamed plaques.
Low ESS associates with inflamed plaque
In this study, we evaluated ESS using a combined approach of 2D velocity-encoded PC-MRI for direct measurement of inlet velocities, 3D reconstruction of thoracic aortas derived from CTA, and standardized state-of-the-art software for CFD, yielding reliable and reproducible ESS calculations. Alternatively, ESS could have been derived from time-resolved 3D velocity-encoding PC-MRI of the aorta, 42 which, however, would require dedicated imaging protocols and time-consuming post-processing calculations. Prior experimental and primarily invasive studies have shown that low ESS promotes atherogenesis and atherosclerotic plaque progression by activating several downstream molecular signalling pathways that regulate lipid accumulation, inflammation, fibrous cap, media thinning, and expansive remodelling. 7, 43, 44 
Study limitations
This study has several limitations. First, MRI and CTA had different spatial resolution, due in part to the lengthy imaging time for MRI and anaesthesia duration. Plaque and vessel area were not assessed in BB-TFE-MRI due to low through-plane resolution. This study required meticulous co-registration of imaging, CFD, and histopathology performed using anatomical landmarks in both the longitudinal and circumferential dimensions. The assumption of laminar flow for our modelling approach may bear aberrations from real flow conditions in certain vascular territories, e.g. branch points. The study population was limited (n ¼ 12 rabbits); however, investigating multiple convex and concave wall subsegments of interest (n ¼ 85, after exclusion of 3 segments) significantly increased the power of the study. This study's design and primary purpose probed the role of different patterns of local ESS in atherosclerosis progression by non-invasive imaging therefore obviating the need for nonatherosclerotic controls. Subsegments with higher ESS and negative features by histopathology served as internal controls. We substantially minimized the longitudinal and circumferential heterogeneity within the aorta by selecting 5-mm-long convex and concave wall subsegments of interest. Finally, H&E-stained sections evaluated the lipid core area of plaques. The paraffin embedding used to preserve the geometry of the perfusion fixed tissues did not permit Oil red O staining.
Conclusion
Serial IRON-MRI in conjunction with USPIOs and high-resolution CTA identified accelerated plaque progression and inflammation progression at 6 months in aortic subsegments of hyperlipidaemic rabbits with low baseline ESS. Non-invasive assessment of local ESS in combination with inflammation affirms the mechanistic link between low ESS and plaque evolution and inflammation. The application of these results has considerable potential to guide therapy and speed the evaluation of novel therapies for atherosclerosis. The findings of this proof-of-concept experimental study now warrant further validation in man.
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Supplementary data are available at European Heart Journal -Cardiovascular Imaging online.
